| Names | |
|---|---|
| Preferred IUPAC name | 4-Aminophenol |
| Other names | 4-Aminophenol p-Hydroxyaniline 4-Hydroxyaniline 1-Amino-4-hydroxybenzene |
| Pronunciation | /ˌpiː əˌmiːnəˈfiːnɒl/ |
| Identifiers | |
| CAS Number | 123-30-8 |
| Beilstein Reference | 1209243 |
| ChEBI | CHEBI:17847 |
| ChEMBL | CHEMBL1409 |
| ChemSpider | 594 |
| DrugBank | DB00215 |
| ECHA InfoCard | 100.013.563 |
| EC Number | 1.10.3.2 |
| Gmelin Reference | 6063 |
| KEGG | C00964 |
| MeSH | D010267 |
| PubChem CID | 4620 |
| RTECS number | SJ7875000 |
| UNII | 20M3QYY44E |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C6H7NO |
| Molar mass | 109.13 g/mol |
| Appearance | White to light purple or brownish crystals |
| Odor | odorless |
| Density | 1.293 g/cm³ |
| Solubility in water | Moderately soluble |
| log P | 0.24 |
| Vapor pressure | 1 mmHg (at 20°C) |
| Acidity (pKa) | 5.5 |
| Basicity (pKb) | 4.74 |
| Magnetic susceptibility (χ) | -62.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.682 |
| Viscosity | 1.284 g/cm³ (20 °C) |
| Dipole moment | 4.61 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 137.0 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -20.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3342 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | N02BE01 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin and eye irritation, may cause allergic skin reaction, and harmful to aquatic life with long lasting effects. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS05,GHS07 |
| Signal word | Warning |
| Hazard statements | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| Precautionary statements | P264, P270, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P311, P312, P321, P330, P332+P313, P337+P313, P362+P364, P405, P501 |
| Flash point | 138°C |
| Autoignition temperature | 300°C (572°F) |
| Lethal dose or concentration | LD50 oral rat 375 mg/kg |
| LD50 (median dose) | 375 mg/kg (oral, rat) |
| NIOSH | RN 123-30-8 |
| PEL (Permissible) | Not established |
| REL (Recommended) | $0.84/g |
| IDLH (Immediate danger) | 5 mg/m3 |
| Related compounds | |
| Related compounds | 4-Nitrophenol Aniline Phenol Acetanilide |
| Product Identification | Industrial Commentary |
|---|---|
|
Product Name: P-Aminophenol IUPAC Name: 4-Aminophenol Chemical Formula: C6H7NO CAS Number: 123-30-8 Synonyms & Trade Names: 4-Hydroxyaniline, p-Hydroxyaniline, Para-aminophenol, PAP HS Code & Customs Classification: 29222990 |
Product and Grade ConsiderationsThe naming and classification for p-aminophenol remain constant across industrial synthesis, but properties crucially differ by grade. For technical production, the degree of purity, physical form—crystalline powder or granular—and color intensity are influenced by purification steps and synthesis route. Grades supplied for pharmaceutical intermediates or photographic applications demand much tighter impurity limits and usually avoid co-crystallized salts, contrary to standard industrial grades where minor process byproducts may dictate color and solubility profile. Raw Material and Process SelectionSelection of aniline or nitrobenzene intermediates translates directly into overall process impurity spectrum. Sulfite-based reduction offers a different impurity profile compared to catalytic hydrogenation methods. Each route generates distinct inorganic and organic side products. For higher-end grades, source control and process design minimize isomeric aminophenols and nitrophenols, which impact color and reactivity in downstream use. The final purification strategy—activated carbon filtration, recrystallization—sets the release benchmark for clarity and ash content. Batch Consistency and QC StrategyBatch uniformity demands ongoing in-process monitoring of reduction endpoints and filtration clarity. Targeted in-process assays typically track color (Lovibond or APHA scale), pH, and specific absorbance, with customer requirements sometimes specifying additional release parameters for melting point tightness or particle size distribution. These downstream characteristics can influence blending, dissolution, and chemical compatibility in pigment, photographic, and pharmaceutical applications. HS Code & Transport ImplicationsP-Aminophenol falls under HS code 29222990, which reflects aromatic monoamines. Finished goods must align with customs requirements for this categorization, as regulatory controls may differ for technical and pharma-intermediate movements. Customs checkpoints often require full detailed assay and impurity disclosure, since some jurisdictions treat such chemicals as controlled due to potential downstream hazardous applications. |
In plant production, p-aminophenol generally presents as an off-white to light gray crystalline solid, often with a faint, characteristic odor. Exact shade can shift due to trace oxidation, especially under prolonged exposure to air, producing pink or brownish hues. Melting point and other thermal properties depend on grade and purity; impurities and residual solvents from process steps can depress melting range. Bulk density and flowability exhibit batch variability, particularly when particle size distribution changes according to downstream application requirements.
Aminophenols are subject to oxidative discoloration—most noted in open storage or if exposed to air and light along the process chain. The chemical remains prone to self-condensation or polymerization, especially under basic or reactive conditions. Handling protocols at production, QA, and logistics are designed to minimize headspace oxygen and moisture exposure. Degradation affects both visual properties and assay, driving all formulation and sampling steps to occur under inert or light-shielded conditions whenever possible.
Solubility in water and organic solvents shows clear temperature and pH dependence; neutral or slightly acidic aqueous media dissolve p-aminophenol efficiently, but high ionic strength or organic cosolvents modulate solubility and dissolution rate. In manufacturing, solution strength and pH are matched to purification or end-use requirements—pharmaceutical, photographic, or fine chemical. Careful filtration and solution preparation ensure removal of undissolved traces and oxidative fines, especially when prepping for batch release or formulation.
Target specifications are established according to downstream sector: pharmaceutical, photographic, or technical/fine chemical. Key release parameters generally include assay, melting range, moisture, ash content, and color metrics (APHA or Hazen). For pharma grades, trace-level reporting for metal and aromatic contaminants is critical. Technical grade targets focus on process economy, less on ultra-low impurity targets.
| Parameter | Typical Range | Relevance |
|---|---|---|
| Assay (%) | Grade-dependent | Impacts effectiveness in end product |
| Moisture | Process- & storage-dependent | Affects stability, crystallinity |
| Color (APHA) | Specified by customer | Critical for photographic use |
| Residue on ignition | Grade-dependent | Indicates inorganic impurities |
| Metal/trace aromatics | Pharma grade focus | Safety/release criteria |
O-nitrophenol, p-nitrophenol, hydroquinone, and oxidative dimers are common process and storage impurities. Impurity levels reflect raw material selection and process control. Control strategy includes process optimization and post-reaction purification. For pharmaceutical markets, impurity thresholds must comply with pharmacopeial or customer monographs; for industrial applications, specification is less stringent but still monitored to ensure functional performance and color requirements.
Assay titration (iodometric or redox), HPLC for trace impurities, and colorimetric methods for color index are most widespread. Moisture is followed by Karl Fischer titration. Metals and specific contaminants for pharma grade require ICP-OES or GC/MS as relevant. Internal batch release standards either align with pharmacopeial monographs or are set by customer-supplied specifications and usage scenario.
Commercial production selects nitrobenzene and iron/acid systems as the most robust—a balance of sourcing security, cost control, and process safety. Raw material quality (nitrobenzene content, metal impurity levels, acid source identity) determines both product outcome and generation of problem impurities. Sourcing from qualified vendors with reliable certificates is routine for regulated grade output.
Reduction of p-nitrophenol (from nitration of phenol or para-nitration of benzene derivatives) using iron powder and acid, or catalytic hydrogenation systems, remains most widely utilized. Route selection considers operational risks, waste management, and downstream purification efficacy. Each major synthesis route bears distinct impurity risk—for example, residual iron or byproduct quinones in iron/acid reduction, and hydrogenation byproduct profile in catalyst-mediated processes.
Reaction temperature and feed rates are set to minimize dimerization and control particle growth. Purification through filtration, crystallization, and multi-stage washing eliminates iron salts, unreacted aromatic nitro compounds, and colored tars. Tight control of pH and redox potential during workup avoids over-oxidation and color body formation. Process water quality, filter media integrity, and environmental oxygen levels all factor into impurity carryover risk and final batch color.
Quality control executes both in-process and post-synthesis analytics—assay, impurity screen, and appearance checks form the release package. Batch homogeneity samples are selected based on lot size and application (pharma and critical photographic grades require more extensive random sampling). Batches that fall outside internal or customer release criteria are reprocessed or downgraded to technical use, never released for regulated applications.
P-aminophenol sees most chemistry in substitution, diazotization, oxidation, and etherification. Derivatives and downstream use pivot on reaction control—N-acylation, O-alkylation, or diazo-coupling for dye, pharmaceutical, or fine chemical intermediates. Limitations arise from susceptibility to oxidation and need for strictly anhydrous or inert conditions to prevent color formation during all transformation stages.
Acidic or basic media, presence of phase transfer catalysts, and controlled temperatures are selected to balance reactivity with avoidance of unwanted side reactions. Manufacturing and R&D both adapt to solvent compatibility and catalyst sensitivity, given the contaminant profile of raw p-aminophenol and application purity needs.
Key uses involve paracetamol, dye precursors, and photographic developers. Downstream manufacturers often request bespoke impurity cutoffs and trace contaminant guarantees based on their end-use risk assessments. Collaborative approach with supply chain partners is standard for process changes affecting downstream synthesis efficiency or regulatory compliance.
Factory and warehouse practice enforces low ambient temperature, low humidity, and total avoidance of direct or UV light—oxidative discoloration and assay decline both accelerate under these conditions. Gas purge (typically nitrogen) is specified for long-term or high-purity storage, especially in drums or lined bulk containers.
Suitable containment uses non-reactive plastics or food/pharma-grade stainless steel. Incompatible materials (iron, copper, aluminum) catalyze color formation and loss of assay. Liner selection is determined by both product purity and user requirements.
Oxidative darkening, moisture caking, and assay drift are monitored throughout storage. Shelf life depends on purity, container design, and environmental control. Inspection intervals are grade- and application-specific; product outside appearance or assay standards is quarantined or reprocessed.
P-aminophenol is classified as hazardous by standard global systems due to potential toxicity by ingestion, skin contact, or inhalation. Detailed hazard and precautionary language follows specific regulatory requirements. Manufacturing aligns labeling and SDS practices with both domestic and export regulations, using the most stringent applicable system as the default.
Potential for skin and eye irritation, sensitization, and acute toxicity is managed by process engineering controls, PPE, and workspace design. Plant staff train on safe handling, first aid, and controlled disposal of contaminated materials as part of operational routine.
Toxicological benchmarks are referenced from globally recognized data sets relevant to intended application. Significant exposure risk drove earlier systemic move to contained transfer, ventilation upgrades, and monitored batch environments. All exposure incidents initiate internal investigation and review of risk control protocols. Customer hazard communications follow best practice guidance for end-use circumstances.
Worker exposure is tracked by continuous or time-weighted air monitoring in operations where powder transfer, drying, or milling take place. Threshold limits, where established by local regulations or customer requirements, set the basis for engineering controls and PPE selection. Operations management regularly reviews occupational data and revises handling protocols when new toxicological or epidemiological evidence arises.
Production of p-aminophenol ties directly to the capacity of the reduction route adopted in-house and the availability of primary feedstocks such as nitrobenzene and hydrogenation catalysts. For large-scale manufacturers in China and India, installed capacity varies from year to year, depending on scheduled plant turnarounds, environmental restrictions, and the offtake from downstream pharmaceutical and dye intermediates sectors. Stock longevity relies on high batch-turnover lines, particularly for pharmaceutical-grade output compared to technical-grade. In Western economies, plant capacity often centers around demand from local pharmaceutical synthesis.
Lead time is significantly affected by demand seasonality and purification load per batch. Typical lead times on standard grades, when feedstocks remain stable, align to 2–4 weeks, but custom grades with bespoke impurity profiles or packaging may require longer. Minimum order quantity is process-route and packaging-dependent, with most producers offering scale from several hundred kilos for technical grades, up to several tons for bulk industrial customers. Custom and GMP lots demonstrate stricter batch segregation; low-volume pharma and hi-purity orders live with longer qualification and retesting cycles.
P-aminophenol packaging must address both moisture protection and contamination control, owing to the compound’s hygroscopic and oxidative reactivity. Technical bulk grades are generally available in lined fiber drums; higher-purity lots target antistatic PE-lined containers or composite drums, sometimes under inert atmosphere if customer requirements justify it. Drum weight and filling mode depend on end use and destination compliance. For pharma and food-contact use, all packaging is batch-segregated and carries full traceability.
Shipping methods reflect the material’s classification and regional customs codes. Bulk shipments within Asian markets may use truck or ocean freight, with temperature controls specified only for critical applications. Express air delivery is reserved for samples, validation, or urgent shortages. Payment follows standard industrial terms—30-60 day credit for established customers, L/C or advance terms for new or high-risk destinations. Some governments require pre-shipment inspection or dual-use documentation.
The price of p-aminophenol directly correlates to global movements in nitrobenzene and aniline, alongside platinum or palladium catalyst costs for reduction processes. Hydrogen pricing and solvent management, including ethanol or methanol utility, can contribute heavily to cost structure at times of energy market disruption. Waste stream treatment costs have risen in regions where local authorities tightened effluent discharge standards, adding a compliance premium to the final product.
Seasonal swings in feedstock price and refinery operation schedules drive immediate upstream volatility. Unplanned plant shutdowns, especially in major producing clusters (Eastern China, Western India), disrupt global balance quickly. Currency fluctuation and export barrier changes create spread between domestic and international contract prices. Regulatory shifts—notably REACH listing in the EU or US EPA monitoring—occasionally interrupt volume shipments or require reformulation of impurity profiles, leading to temporary price increments.
Price gaps between grades stem from raw material lot selection, extent and method of purification, impurity control rigor, and packaging certification. Technical grade, used for dye and photographic purposes, draws on broader in-process control but less stringent final impurity release. Pharmaceutical and electronics grades require narrower impurity bands, multi-stage recrystallization, and increased batch traceability, increasing both cost and lead time. Packaging certified for GMP or food-contact carries cost increments for segregated lines, validation testing, and serialization. Certification for specific markets (e.g., EU commission standards or US FDA) can add analytical and documentation overhead, reflected in offered price bands.
Demand for p-aminophenol stems from API synthesis (notably paracetamol/acetaminophen), dyes, and photographic chemicals. Demand cycles tightly with pharma output trends and global health events. Major supply clusters exist in China, India, Western Europe, and the US, with smaller capacity spread in Japan for local advanced material production. Over the last three years, pandemic-related demand surges for API drove short-term price highs, which have since moderated as capacity expansions and destocking took effect.
US and EU plants focus primarily on high-purity lots for GMP manufacture. Local regulatory factors frequently raise cost per kilo above Asian output, but guarantee traceability and shorter lead times. Japan aligns capacity to electronics and specialty chemical demand, emphasizing low-trace-metal content. Indian producers have ramped up output for both global export and strong domestic API conversion. China continues to account for the largest volume output, leveraging dense chemical park infrastructure.
Forward pricing projects moderate growth, weighted by expected continuous demand in paracetamol synthesis and stabilization of feedstock supply chains. Anticipated environmental upgrades in Asian manufacturing hubs will likely continue to add incremental compliance costs, especially for effluent control and certifications. No major new capacity additions are projected outside China and India, tightening supply for certain high-purity applications in Western markets. Currency and international logistics cost movements will play a secondary role, except during acute shipment disruptions. Analysts forecast a steady but moderate price uplift by 2026, with sharper premiums for pharmaceutical and electronic material grades requiring tighter impurity release.
Forecasts rely on a survey of market intelligence from chemical market reporting agencies, price benchmarks maintained by independent industry pricing services, and in-house production economics compared year-on-year with published financials from leading manufacturers. Regulatory and environment-linked cost influences reflect published government agency notices in key producing countries.
Recent months have seen phased implementation of new wastewater discharge limits in key Asian production parks, affecting available capacity for p-aminophenol and related intermediates. Major end-users in the paracetamol value chain have renegotiated annual offtake agreements tied to modified price indexation formulas, reflecting greater volatility in feedstock costs. Tier-one producers have begun pilot runs of advanced catalyst recovery systems, seeking to manage future platinum group metal cost exposure.
Both EU and US agencies continue to refine impurity notification protocols for primary amines and aromatic intermediates in pharmaceutical uses. Continued REACH vigilance emphasizes trace-level reporting of nitrosamine-forming precursors and metal residues. Indian export consignment inspection protocols have increased batch release documentation requirements, reinforcing the need for process and packaging segregation.
Manufacturers have responded by upgrading process analytics and batch tracking infrastructure to meet ever-tighter impurity benchmarks. Several suppliers have diversified catalyst sourcing and adopted closed-loop recycle for solvents to offset utility cost rises and environmental limits. Enhanced quality documentation, including full chain-of-custody records for pharma and food-contact grades, remains a central focus to anticipate new customer specification trends and regulatory scrutiny.
P-aminophenol plays a central role in various sectors. Its primary application remains as the intermediate in the synthesis of paracetamol (acetaminophen) in the pharmaceutical industry. Beyond pharmaceuticals, P-aminophenol supports dye manufacturing, photographic developer solutions, and specialty chemicals. Each sector imposes distinct technical criteria, both in terms of chemical purity and contaminant considerations.
| Application | Recommended Grade | Special Notes |
|---|---|---|
| Paracetamol API Manufacture | Pharmaceutical Grade | Low heavy metals, minimal byproduct amines, tight color and impurity profile |
| Dye and Pigment Production | Technical/Industrial Grade | Higher tolerance for colored impurities and residual salts, focus on conversion yield |
| Photographic Chemicals | Photographic/High-Purity Grade | Low oxidizable impurities, stringent chloride content control |
| Laboratory Reagents | Reagent Grade | Label-specific, batch COA confirmation required |
In direct synthesis for paracetamol, the critical parameters focus on:
The intended use directly sets the priority between purity, cost, and secondary specification concerns. For instance, traceability and impurity thresholds matter far more in API synthesis than in textile colorant intermediates.
Local, regional, and end-market regulations often dictate allowable impurity levels or batch traceability. Pharmaceutical use in regulated markets requires adherence to pharmacopeial standards, validated through documentation and lot-wise COAs. Non-pharmaceutical applications, especially export, must address importing country environmental and quality norms.
Different synthesis routes used in manufacturing generate different impurity profiles. Pharmaceutical and photographic uses rely on grades with reduced aromatic amine and nitroaromatic residues. Industrial dye sectors may tolerate higher levels, provided functional groups are within established reactivity margins.
Economies of scale affect the achievable specification and supply timeline. Small-volume pharmaceutical customers can receive tailored purification and documentation, adding cost. Bulk industrial customers typically prefer standard technical grades where cost control outweighs maximum purity.
Before plant-scale purchasing, validate the grade’s performance in the actual process. Sample analysis connects real process yield and downstream impact to all published COA parameters. Manufacturer technical support can advise which internal test points align best with your application requirements.
Quality management in the production of P-aminophenol relies on systematized process control combined with independent batch verification. For industrial supply, ongoing audit cycles focus on process reproducibility, raw material qualification, and traceability. Many customers require plant certification to ISO 9001 or equivalent. Certification scope may extend to additional standards if requested for pharma or food-contact applications, but not all grades or batches carry those credentials as a default. Routine internal audits review the adherence of all operational and documentation procedures to maintain regulatory standing and traceability from raw material to packed product. Third-party verifications for environmental and safety standards are addressed during customer-specific audits, frequently focused on compliance with specific export or application-region requirements.
For pharmaceutical or photographic applications, customers may require supply backed by GMP or tailor-made certification. Certification to such frameworks is grade- and contract-dependent. Higher-purity pharmaceutical grades follow stricter documentation and batch-release procedures than standard technical-grade batches. Custom supply for regulated end-uses can incorporate additional lot-level certifications, but these require clear agreement at the purchase order stage. Certificate deliverables are aligned with the batch release parameters, including origin, impurity profile, retest status, and stability comments linked to the actual grade.
Typical technical documentation packages cover certificate of analysis, specification confirmation, manufacturing route disclosure (if contractually required), and regulatory documentation such as REACH, TSCA, or other export compliance declarations. Material Safety Data Sheets are standardized for each grade, reflecting intended or likely downstream applications and storage details. Production route-specific details — including primary raw material sources, by-product minimization strategies, and control points for impurity classes — can be provided for audit or regulatory clearance purposes. Lot tracking and retest data are maintained to support any required traceability or recall process, with retention protocols set according to both regulation and customer requirement.
Manufacturing at commercial scale requires both stable sourcing of critical raw materials and established process routines. Long-term supply contracts rely on a balanced alignment of forecasted demand with scheduled production campaigns, and preferred customers often participate in pre-season demand negotiation to lock in supply priorities or call-off rights. For spot or project-based business, flexible cooperation plans allow scheduling batch production according to mutually agreed timelines and specification adaptation. This approach helps accommodate shifts in market demand or application revisions requiring narrow windows of specification.
Core production capacity for P-aminophenol is determined by actual installed equipment, workforce allocation, and input availability, rather than catalog figures. Regular maintenance and replacement schedules ensure controlled output with minimized unscheduled downtime. To support critical contract customers, reserve capacity buffers may be maintained, generally dependent on forecasted project volumes and the strategic value of the application segment. For highly critical (pharma or high-value specialty) supply chains, backup or dual manufacturing lines are sometimes used for redundancy, subject to product grade and sensitivity.
Sample provision adheres to both regulatory shipment and confidentiality considerations. Typical industrial samples are pulled and packed under the same documented lot release process as commercial shipments, including full certificate documentation. For new formulations or joint-development programs, sample quantities, documentation extent, and packing methodology are negotiated to ensure technical and commercial alignment. Traceability of sample material is maintained, allowing future scale-up requests to reference tested batches.
Flexible cooperation models are shaped by customer-specific logistics, regulatory spacing, and specification requirements. For customers with variable offtake or season-sensitive demand, supply agreements are established with adjustable call-off volumes, shipment period windows, or mixed packaging arrangements. For downstream value-adders or converters, batch reservation and toll processing modes open lines for customer-supplied specifications or alternate QA/analytical input. Joint R&D or process-adaptation cooperation can be entered, with production and technical teams working in direct contact with customer project leads. Frequent communication between operations and procurement ensures alignment on forecast updates, batch priorities, and any downstream compliance documentation required for market entry.
Research on p-aminophenol (PAP) focuses on refining reaction routes to reduce impurity formation, improve yield, and lower energy input. Technical teams are evaluating catalyst technologies in hydrogenation steps, as variations in selectivity strongly impact purity control and downstream reproducibility. Selection of raw phenol and nitrobenzene feedstocks remains critical; batch-to-batch minor impurity profiles persist as a challenge, especially for pharmaceutical and photographic applications which demand higher specification tiers.
Recent interests have expanded beyond analgesic and antipyretic API intermediate use. The pigment and electronics industries seek PAP with controlled particle size and minimal trace metal content. Water treatment developers also explore its reducing properties in newer analytical reagent formulations, driving requests for grades with precisely-defined soluble impurity levels.
Production bottlenecks center on process upsets due to temperature excursions, leading to colored by-product generation and batch failures. Refinement of crystallization protocols and mother liquor recovery techniques has improved batch yield, but remains sensitive to input purity and cooling rate management. In-situ monitoring for process tracking has contributed to batch-to-batch reproducibility and allowed for specific tailoring per application, particularly for pharmaceutical precursor routes.
Demand for PAP tracks closely with global paracetamol (acetaminophen) output, which is expected to show steady growth, mainly from Asia-Pacific processors. Increased interest in high-purity grades from specialty pigment and electronics chemical manufacturers provides opportunities for capacity diversification. Market volatility may arise due to raw material pricing and regional regulatory shifts impacting production economics and specification standards.
Continuous hydrogenation units and advanced filtration systems are gradually replacing traditional batch setups. This transition allows for tighter impurity control and more efficient solid-liquid separation. Adoption of online impurity monitoring and automated batch tracking systems is reducing manual intervention, especially in high-volume facilities aiming for low variance and high throughput.
Pressure mounts to minimize waste streams and solvent consumption. Some lines have shifted toward catalytic hydrogenation routes with water as solvent, where local infrastructure supports solvent recovery and closed-loop processing. Waste minimization strategies often integrate with regional environmental standards, making zero-discharge concepts more feasible in newly commissioned projects. The design of purer, more feedstock-efficient syntheses remains an active topic in joint industry-university projects targeting both cost and sustainability.
Technical staff supports customers through analysis of critical-to-quality attributes, such as trace impurity profiles, color stability under storage, and compatibility with downstream formulations. Recommendations are tailored to site-specific operational conditions and end-use regulatory requirements, from API intermediates to specialty pigments.
For customers encountering crystallization or formulation bottlenecks, technical teams assist by sharing process parameters that affect product performance, including filtration rates, moisture control during storage, and re-dissolution behavior. Scale-up guidance is based on feedback from laboratory and pilot plant trials, which often reveal grade-dependent sensitivities not reported at smaller scale.
Commitment extends to root cause analysis should performance in final application deviate from expectations. Batch traceability records and retained sample management systems enable prompt investigation. Where specification tailoring is required, joint process reviews with customer teams can establish product grades fit for specific operational requirements.
As a direct manufacturer of P-aminophenol, our commitment covers every stage from synthesis to shipment. Our production facility operates with closed-loop process controls that allow precise management of raw material input, temperature, reaction time, and purification. We produce P-aminophenol in batches tailored to industrial scale, maintaining minimized in-process variability to keep lot-to-lot analysis within strict accepted ranges. Batch records include in-process monitoring to ensure finished product meets established purity benchmarks.
P-aminophenol features as a primary intermediate for paracetamol (acetaminophen), serving some of the world’s largest API makers. It also acts as a fundamental input in dye manufacturing—supporting the production of both azo and oxidative hair dyes—and as a key developer in photographic chemistry. Industrial buyers turn to our P-aminophenol because it passes GC, HPLC, and melting point controls aligned with global pharmacopoeia and technical standards. This enables downstream processes to run uninterrupted, reducing costly stoppages and rework.
We conduct every stage of production using automated dosing and temperature regulation to preempt off-specification output. Finished product goes through a quality laboratory for impurity profile, moisture content, and residue solvent testing. Release criteria follow customer-defined analytical methods, not just internal standards. Shipment leaves the factory only after COA approval, which reduces downstream disputes and secures production continuity for our customers. Our P-aminophenol supports demanding standards from high-volume pharmaceutical lines down to specialty chemical blends.
We offer P-aminophenol in multiple packaging configurations fit for facility requirements, from 25 kg fiber drums to bulk container options. Strict powder-handling protocols minimize contamination and reduce potential for transit loss. Our dedicated logistics team organizes both domestic and international shipments from the factory, with traceability at every step. This approach reduces handling risks and enables accurate delivery timeline forecasting.
Our factory provides technical support directly from production chemists and engineers, not intermediaries. We assist customer production teams with application guidance and troubleshooting based on actual plant performance data. Whether it involves process adaptation for scale-up, analytical validation, or regulatory filing requirements, our personnel bring hands-on experience from manufacturing floors to customer sites. This enables faster resolution of technical issues and facilitates new project onboarding.
Direct access to factory output supports risk management for industrial users. Manufacturers gain increased visibility into batch scheduling, raw material traceability, and real-time quality feedback. Distributors benefit from assured supply availability and access to fresh production runs. Procurement teams value stable contract pricing, coupled with the assurance that supply does not rely on variable third-party inventories. Our capability to customize shipments for timing, packaging style, and analysis method creates real-world efficiency for high-volume buyers.
Our history in P-aminophenol production gives industry partners a predictable and transparent supply channel, focused on operational reliability and measurable compliance. As industrial product needs evolve, we continue investing in technical upgrades and process optimization to deliver value across every link of the supply chain.
As direct manufacturers of P-aminophenol, we recognize that laboratories seek more than chemicals by name; they rely on consistent assay and clear, reliable purity specifications. Our manufacturing team addresses this by designing every batch for traceability, reproducibility, and accurate composition. P-aminophenol, a key intermediate for developing dyes, photographic developers, and pharmaceuticals, serves customers who cannot afford uncertainty in the purity profile of their reagents.
Laboratory users expect a transparency that matches rigorous quality controls. Our standard grade of P-aminophenol maintains an assay above 98% (on dried basis). Impurities, such as moisture, residual aniline, or oxidation by-products, are tightly controlled, as these can disrupt sensitive analytical and synthetic applications. Moisture content undergoes IR drying and automatic titration to prevent variability that could skew precision reactions.
In our facility, we maintain clear boundaries for trace organics, controlling by-products below the strict limits recognized by reference compendia such as ACS or pharmacopoeias. Routinely, our analytical chemists test multiple sample points from each batch, not just at completion but throughout processing, relying on validated HPLC, GC, and UV-Vis protocols aligned with international methodologies.
Assay specifications are never a guess. Labs that require P-aminophenol above 98% are always sensitive to the presence of colored oxidation products or aminophenol isomers, which compromise colorimetric tests and catalyzed reactions. This challenge drives us to maintain strict environmental conditions—from filtration to inert gas blanketing—so that oxidative degradation during production and in storage is kept in check.
Some end users have applications demanding even higher purities or lower trace ion concentrations than common grades provide. Our technical team supports this by adjusting synthesis parameters and purification protocols, whether through additional recrystallization or specific removal of heavy metal residues by chelation techniques. Each adjustment goes through a documented evaluation, so changes do not introduce unintended side-products or destabilize the main assay profile.
Our chemists do not just certify to a specification; we ensure each batch ships with a certificate of analysis detailing moisture content, individual impurity levels, and assay by relevant methods. Laboratories can plan their usage based on the worst-case impurity profile, not just an average figure. Differential Scanning Calorimetry (DSC) and melting point ranges help confirm identity and purity, giving laboratories further assurance their results are reliable and comparable year to year.
Direct access to raw lab feedback means our manufacturing team responds rapidly to trends in analytical needs or new regulatory thresholds. If national standards change or an emerging market requires adaptations, our process engineers pilot the necessary upgrades in real-time. Through this, we do more than meet standard assay requirements—we anticipate higher benchmarks and maintain the flexibility to support evolving research.
Delivering P-aminophenol with a reliable, high assay specification ensures that clients in research, pharmaceutical, and technical fields can pursue innovation without interference from inconsistent raw material quality. Our focus on data-driven process control and transparent documentation forms the backbone of dependable laboratory chemistry.
At our manufacturing plant, the lead time for P-aminophenol stands as one of the biggest focal points for buyers looking to plan their procurement cycles. For regular orders, our standard production flow enables dispatch within three to four weeks from receipt of confirmed purchase order, subject to raw material availability and factory loading. Our facilities run multiple shifts and maintain robust inventory buffers for the most essential intermediates, ensuring we avoid production delays that commonly affect less vertically integrated manufacturers.
Shorter lead times are possible for repeat buyers and those with rolling forecasts. For highly specific grades or custom purity profiles, additional time for process adjustment and QA testing may apply. We advise committed customers to provide demand forecasts, as schedule certainty allows us to reserve production slots and deliver with even sharper consistency. Open, practical planning minimizes risk on both sides, especially in volatile market sections impacted by precursor sourcing or logistics disruptions.
We manufacture at industrial scale, so volume thresholds ensure that our plant operates efficiently and delivers competitive pricing. Our minimum order quantity for P-aminophenol is set at 500 kilograms. This figure reflects the smallest practical batch that maintains high product quality and justifies the fixed costs involved in cleaning, setup, validation, and safe packaging. Buyers below this threshold often see disproportionate cost increases due to handling and compliance steps necessary for safe product delivery.
Bulk orders above a metric ton unlock even sharper cost positions and reduced per-kilo freight rates. We encourage long-term partners to optimize their procurement cycles, as consistent order volumes also give our production planners the clearest signals and help prevent avoidable bottlenecks or sudden stock-outs.
Our packaging solutions for P-aminophenol revolve around safety, product integrity, and logistic efficiency. We primarily use fiber drums lined with double polyethylene bags. Our standard drum holds 25 kilograms net, universally accepted for both domestic and export transportation under chemical shipping regulations. Each drum is sealed with a tamper-evident ring and carries clear batch labeling, precise net weight, and a QR-coded traceability seal. Each pallet typically contains 16 to 20 drums, stretch-wrapped for stability.
For larger volume buyers, we offer 500 kilogram and 1 metric ton composite containers, which further reduce waste and manual handling. We recommend bulk packaging only for customers with mechanical unloading setups and suitable warehousing. All packaging materials meet current international standards for hazardous chemical transport and are regularly reviewed for compliance with ADR, IMDG, and IATA guidelines. Detailed packaging diagrams and MSDS sheets are provided in advance, helping buyers to update internal handling SOPs and warehouse records before each consignment lands.
Manufacturing P-aminophenol is never just about producing a chemical to spec. Our responsibility extends to clear, actionable information about lead times, batch size, and packaging methods. Having robust answers to these supply questions lets procurement professionals make more effective choices, avoid inventory emergencies, and keep their own process flows running without disruption. Open dialog with direct manufacturers like us puts supply chain managers in a stronger position, facing fewer surprises and sharper overall cost control.
P-aminophenol is an essential building block for several industries, especially in pharmaceuticals and dyes. Our experience manufacturing this compound spans over a decade, and over the years, we have worked closely with regulators and customers to ensure compliance with transport and storage standards.
P-aminophenol holds a specific status under hazardous materials regulations during transit. According to the UN classification system, it falls under UN 2512 as a toxic solid, organic, n.o.s. (not otherwise specified). International transportation, whether by road, air, or sea, requires the correct identification and packing group assigned by both the International Air Transport Association (IATA) and International Maritime Dangerous Goods (IMDG) code. It is classified as Dangerous Goods, and shipping without proper labeling or documentation can lead to severe regulatory penalties. We always label our containers with the required hazard pictograms, classification info, and emergency procedures in line with global transport standards. Our logistics team coordinates with recognized carriers trained in handling regulated cargo for all shipments, ensuring every package arrives safely and in compliance with regional and international laws.
Many customers ask us about the safest way to store p-aminophenol. We advise storing it in a cool, dry, well-ventilated area away from incompatible substances like oxidizing agents or strong acids. The compound tends to oxidize easily, leading to degradation and loss of performance. By limiting exposure to air, light, and moisture, shelf life is maximized and color stability maintained. Our production facilities use lined fiber drums or HDPE containers, designed for indoor storage and equipped with tamper-evident seals. Each batch is packed to minimize headspace, reducing the risk of oxidation during storage. Temperature between 15°C and 25°C helps preserve quality over time. In larger operations, local exhaust ventilation assists in controlling dust and vapor, while spill containment pallets prevent environmental release in case of leaks. We provide detailed storage guidelines with every consignment to help our partners maintain compliance and ensure operator safety.
Direct contact or inhalation of p-aminophenol powder poses health risks such as skin irritation, respiratory discomfort, or more severe toxic effects in high concentrations. Our technical team recommends using chemical-resistant gloves, safety goggles, and long-sleeved clothing during handling. Where dust generation is possible, a suitable dust mask or respirator minimizes exposure. In our own facilities, handling procedures involve closed transfer systems and regular air monitoring, keeping airborne concentrations below recommended occupational exposure limits. Decontamination stations and emergency showers are standard on our production floor, providing additional measures to ensure safety. Spill kits equipped with absorbent material and neutralizing agents remain on hand for immediate response, cutting down on potential risk from incidental releases.
We regularly review and update our handling and storage protocols in line with regulatory changes. We rely on certified third-party audits to confirm our processes uphold the latest standards for both workplace and environmental safety. Our technical support group assists downstream users with interpreting safety data, offering practical recommendations based on real-world manufacturing experience.
Through robust controls across our production and logistics chain, we bring customers a quality-guaranteed product while minimizing occupational and environmental risks. Adhering to these best practices ensures the safe and compliant use of p-aminophenol throughout its journey—from factory floor to laboratory bench.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
